These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35291445)

  • 1. Olfactomedin 4 Is a Biomarker for the Severity of Infectious Diseases.
    Liu W; Rodgers GP
    Open Forum Infect Dis; 2022 Apr; 9(4):ofac061. PubMed ID: 35291445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A neutrophil subset defined by intracellular olfactomedin 4 is associated with mortality in sepsis.
    Kangelaris KN; Clemens R; Fang X; Jauregui A; Liu T; Vessel K; Deiss T; Sinha P; Leligdowicz A; Liu KD; Zhuo H; Alder MN; Wong HR; Calfee CS; Lowell C; Matthay MA
    Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L892-L902. PubMed ID: 33355521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Olfactomedin-4-Defined Human Neutrophil Subsets Differ in Proteomic Profile in Healthy Individuals and Patients with Septic Shock.
    Lundquist H; Andersson H; Chew MS; Das J; Turkina MV; Welin A
    J Innate Immun; 2023; 15(1):351-364. PubMed ID: 36450268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactomedin 4 marks a subset of neutrophils in mice.
    Alder MN; Mallela J; Opoka AM; Lahni P; Hildeman DA; Wong HR
    Innate Immun; 2019 Jan; 25(1):22-33. PubMed ID: 30537894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olfactomedin 4-Positive Neutrophils Are Upregulated after Hemorrhagic Shock.
    Kassam AF; Levinsky NC; Mallela JP; Angel K; Opoka A; Lahni P; Sahay RD; Fei L; Nomellini V; Wong HR; Alder MN
    Am J Respir Cell Mol Biol; 2021 Feb; 64(2):216-223. PubMed ID: 33253592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactomedin 4 inhibits cathepsin C-mediated protease activities, thereby modulating neutrophil killing of Staphylococcus aureus and Escherichia coli in mice.
    Liu W; Yan M; Liu Y; McLeish KR; Coleman WG; Rodgers GP
    J Immunol; 2012 Sep; 189(5):2460-7. PubMed ID: 22844115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer.
    Liu W; Rodgers GP
    Cancer Metastasis Rev; 2016 Jun; 35(2):201-12. PubMed ID: 27178440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactomedin-4-Positive Neutrophils in Neonates: Link to Systemic Inflammation and Bronchopulmonary Dysplasia.
    Al Gharaibeh FN; Kempton KM; Alder MN
    Neonatology; 2023; 120(1):40-48. PubMed ID: 36549285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal characterization of olfactomedin-4 expressing neutrophils in pediatric patients undergoing bone marrow transplantation.
    Stark JE; Opoka AM; Fei L; Zang H; Davies SM; Wong HR; Alder MN
    PLoS One; 2020; 15(5):e0233738. PubMed ID: 32470072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactomedin 4 contributes to hydrogen peroxide-induced NADPH oxidase activation and apoptosis in mouse neutrophils.
    Liu W; Liu Y; Li H; Rodgers GP
    Am J Physiol Cell Physiol; 2018 Oct; 315(4):C494-C501. PubMed ID: 29949402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactomedin 4 defines a subset of human neutrophils.
    Clemmensen SN; Bohr CT; Rørvig S; Glenthøj A; Mora-Jensen H; Cramer EP; Jacobsen LC; Larsen MT; Cowland JB; Tanassi JT; Heegaard NH; Wren JD; Silahtaroglu AN; Borregaard N
    J Leukoc Biol; 2012 Mar; 91(3):495-500. PubMed ID: 22187488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile OLFM4-null mice are protected from sepsis.
    Stark JE; Opoka AM; Mallela J; Devarajan P; Ma Q; Levinsky NC; Stringer KF; Wong HR; Alder MN
    Am J Physiol Renal Physiol; 2020 Mar; 318(3):F809-F816. PubMed ID: 32068457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olfactomedin-4 in digestive diseases: A mini-review.
    Wang XY; Chen SH; Zhang YN; Xu CF
    World J Gastroenterol; 2018 May; 24(17):1881-1887. PubMed ID: 29740203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactomedin-4
    Huber A; Jose S; Kassam A; Weghorn KN; Powers-Fletcher M; Sharma D; Mukherjee A; Mathew A; Kulkarni N; Chandramouli S; Alder MN; Madan R
    bioRxiv; 2023 Aug; ():. PubMed ID: 37662327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfm4 deletion enhances defense against Staphylococcus aureus in chronic granulomatous disease.
    Liu W; Yan M; Sugui JA; Li H; Xu C; Joo J; Kwon-Chung KJ; Coleman WG; Rodgers GP
    J Clin Invest; 2013 Sep; 123(9):3751-5. PubMed ID: 23908114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human neutrophil subsets defined by the presence or absence of OLFM4 both transmigrate into tissue in vivo and give rise to distinct NETs in vitro.
    Welin A; Amirbeagi F; Christenson K; Björkman L; Björnsdottir H; Forsman H; Dahlgren C; Karlsson A; Bylund J
    PLoS One; 2013; 8(7):e69575. PubMed ID: 23922742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer.
    Li H; Kim C; Liu W; Zhu J; Chin K; Rodriguez-Canales J; Rodgers GP
    Int J Cancer; 2020 Mar; 146(5):1346-1358. PubMed ID: 31241767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma olfactomedin 4 level in peripheral blood and its association with clinical features of breast cancer.
    Liu C; Guo Y; Wu W; Zhang Z; Xu L; Wu K; Hu W; Liu G; Shi J; Xu C; Bi J; Sheng Y
    Oncol Lett; 2017 Dec; 14(6):8106-8113. PubMed ID: 29344255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactomedin 4 deficiency promotes prostate neoplastic progression and is associated with upregulation of the hedgehog-signaling pathway.
    Li H; Liu W; Chen W; Zhu J; Deng CX; Rodgers GP
    Sci Rep; 2015 Nov; 5():16974. PubMed ID: 26581960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection.
    Liu W; Yan M; Liu Y; Wang R; Li C; Deng C; Singh A; Coleman WG; Rodgers GP
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):11056-61. PubMed ID: 20534456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.